Table 1.
Demographics | N (%) or Mean ± SD |
Clinical Characteristics | N (%) or Mean ± SD |
---|---|---|---|
Age at Diagnosis | Stage of Breast Cancer | ||
Mean age±SD | 55.29±10.31 | In situ-Stage 0 | 193 (22%) |
Marital Status | Localized-Stage I | 342 (40%) | |
Married | 473 (57%) | Regional-Stage II a | 160 (19%) |
Widowed | 105(13%) | Stage II b | 82 (10%) |
Divorced/Separated | 190 (22%) | Stage III a | 19 (2%) |
Never Married | 57 (7%) | Unstaged | 60 (7%) |
Education | Adjuvant Therapy | ||
≤ High School Graduate | 218 (25%) | None | 274 (32%) |
Some College | 311 (36%) | Radiation Therapy | 313 (37%) |
College Graduate | 166 (19%) | Chemotherapy | 82 (9%) |
Graduate School | 161 (19%) | Radiation Therapy and Chemotherapy | 188 (22%) |
Employment Status | Surgery | ||
Working | 474 (57%) | No Surgical Procedure | 14 (2%) |
Not working – leave, retired, unemployed | 319 (37%) | Partial Mastectomy | 552 (64%) |
Not working - disabled | 33 (4%) | Total/modified Mastectomy | 290 (34%) |
Income | Tamoxifen at follow-up | ||
≤ 20,000 | 148 (18%) | No | 460 (56%) |
20,001 – 50,000 | 284 (33%) | Yes | 368 (44%) |
50,001 – 70,000 | 222 (27%) | ||
≥70,000 | 118 (14%) | ||
Race/Ethnicity | Lymphedema | ||
Non-Hispanic Caucasian | 506 (67%) | Never | 681 (79%) |
Non-Hispanic African American | 224 (30%) | Yes, not current | 49 (6%) |
Non-Hispanic Other | 25 (3%) | Yes, current | 127 (15%) |
Ethnicity: Hispanic | 102 (12%) | ||
Menopausal Status | Bothered by Lymphedema in Past 3 Months | ||
Post-menopausal | 628 (76%) | Not at all | 49 (28%) |
Pre-menopausal | 151 (18%) | A little/ A fair amount | 108 (61%) |
Unclassifiable | 49 (6%) | Much/Very much | 19 (11%) |
Smoking Status | BMI | ||
Not at all (or N/A) | 729 (85%) | < 25 | 377 (44%) |
Every day | 71 (9%) | 25–29 | 239 (28%) |
On some days | 28 (3%) | ≥ 30 | 241 (28%) |
Comorbidities | SEER Site | ||
0 | 215 (26%) | New Mexico | 457 (53%) |
1–2 | 400 (47%) | Western Washington State | 177 (21%) |
≥3 | 213 (25%) | Los Angeles County | 223 (26%) |
# Comorbid Conditions that Limit Activities | Hormone Receptors | ||
0 | 618 (75%) | Estrogen receptor positive (ER+) | 480 (56%) |
1 | 145 (18%) | Progesterone receptor positive (PR+) | 386 (45%) |
2 | 38 (5%) | Antidepressants at Follow-Up | |
3–4 | 27 (2%) | Yes | 128 (15%) |